| Term 
 | Definition 
 
        | Transportation Regulation
 Protection
 |  | 
        |  | 
        
        | Term 
 
        | What substances does the blood transport? |  | Definition 
 
        | Oxygen and nutrients Metabolic waste
 Hormones
 Molecules to be modified
 |  | 
        |  | 
        
        | Term 
 
        | What does the blood regulate? |  | Definition 
 
        | pH body temperature
 fluid volume
 |  | 
        |  | 
        
        | Term 
 
        | How does blood help protect the body? |  | Definition 
 
        | -Prevents blood loss through clot formation with platelets and plasma proteins -Prevents infection with antibodies, WBCs, and complement proteins
 |  | 
        |  | 
        
        | Term 
 
        | What type of tissue is blood? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What are the components of blood? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What percentage of blood is made of plasma? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What percentage of blood is formed elements? |  | Definition 
 
        | They make up 45% of blood |  | 
        |  | 
        
        | Term 
 
        | Physical characteristics of blood |  | Definition 
 
        | -Denser/more viscous than water -38 degrees C (100.4 degrees F)
 -7.35-7.45 pH / slightly alkaline
 -makes 8% of body weight
 -average blood volume 5L (4-5L females, 5-6L males)
 -blood volume and pressure are constant
 -EPO hormone regulates pressure and vol.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | liquid containing suspended particles that do not settle out of solution -ex. plasma
 |  | 
        |  | 
        
        | Term 
 
        | What percentage of formed elements are red blood cells? |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | White blood cells and platelets -make up <1% of blood volume
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Complete Blood Count Includes:
 -RBC, WBC, and platelet counts
 -Differential WBC count
 -Hematocrit
 -hemoglobin in g/mL
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Percentage of red blood cells |  | 
        |  | 
        
        | Term 
 
        | Differential white blood cell count |  | Definition 
 
        | Count of various white cells and portions -detects inflammation, blood disorders, and poison effects
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Red blood cell count >65% |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -infants 14-20g/100mL -adult female 12-16g/100mL
 -adult male 13.5-18g/100mL
 |  | 
        |  | 
        
        | Term 
 
        | Characteristics of blood plasma |  | Definition 
 
        | -straw-colored, sticky -91.5% water, over 100 dissolved solutes
 -plasma protein = 7% by weight of plasma volume
 -dissolved substances = 2% plasma volume
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -made by liver 
 Albumin
 Globulins
 Fibrinogen
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -plasma protein -makes up 55-60% of all plasma proteins
 -carrier of fatty acids, bilirubin, and thyroid hormones
 -blood buffer
 -contributes to blood colloid osmotic pressure
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -plasma protein -makes up 38% of plasma proteins
 -some are antibodies
 -some are transport molecules
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -plasma protein -makes up 4-7% of plasma proteins
 -functions in clotting
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | blood plasma minus the clotting proteins -straw colored liquid
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | blood cell production in red bone marrow (formed elements)
 -negative feedback system
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Stem cell from which all formed elements are derived |  | 
        |  | 
        
        | Term 
 
        | Two precursor cells derived from hemocytoblasts |  | Definition 
 
        | -Myeloid stem cells -Lymphoid stem cells
 |  | 
        |  | 
        
        | Term 
 
        | Myeloid stem cells can form what cell types |  | Definition 
 
        | RBCs platelets
 granulocytes
 monocytes
 |  | 
        |  | 
        
        | Term 
 
        | Lyphoid stem cells can form what type of cells |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Hemopoietic growth factors |  | Definition 
 
        | Erythropoietin (EPO) Thrombopoietin (TBO)
 Cytokines
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | hemopoietic growth factor - hormone produced in kidneys
 - stimulates production of red blood cell precursors
 - tested in anemic patients
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | hemopoietic growth factor - hormone produced by liver
 - stimulates formation of platelets
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | hemopoietic growth factor - small glycoproteins produced by red bone marrow, leukocytes, macrophages, fibroblasts, and endothelial cells
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | 5 million RBC/mm3 -females 4.8 million RBC/mm3
 -males 5.4 million RBC/mm3
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | lack a nucleus and mitochondria |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | pigment of RBC bind to oxygen and give red color |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | protein of hemoglobin, has a quaternary structure -4 polypeptide chains
 -2 alpha, 2 beta
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -globin protein -heme pigment
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | pigment of hemoglobin -contains iron molecule
 -one heme for each 4 globin proteins
 -iron molecule in heme binds with oxygen
 |  | 
        |  | 
        
        | Term 
 
        | How many oxygen molecules can a hemoglobin molecule transport? |  | Definition 
 
        | -transports 4 Oxygen from lungs to tissues -transports CO2 back to the lungs
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | hemoglobin that has been oxygenated and is bright red |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | hemoglobin that contains no oxygen and is darker red |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | hemoglobin that is transporting CO2 attached to globin |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | How many RBCs are destroyed every second? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | How many RBCs are in circulation? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Were does phagocytosis of RBCs take place? |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | -globin and heme are split apart -globin broken down to amino acids and used to make new proteins
 -iron combines with plasma protein to form transferrin, then attaches to iron storage proteins ferritin and hemosiderin
 -Fe reattaches to transferrin, travels to red bone marrow to make more RBCs
 -non-Fe portion of heme becomes biliverdin(green pigment), then bilirubin(yellow-orange pigment)
 -bilirubin secreted into bile
 -some bilirubin becomes urobilin (yellow pigment in urine)
 -most bilirubin eliminated in feces as stercobilin(brown pigment)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | precursor cell to RBC found in red bone marrow |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | precursor to RBCs -gives rise to cells that synthesize hemoglobin
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | precursor to RBC -nucleus has been ejected from cell
 -34% hemoglobin
 -.5-1.5% of all RBCs in a RBC count
 -become erythrocytes in 1-2 days
 |  | 
        |  | 
        
        | Term 
 
        | Stimulus of RBC production |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | -made in the kidneys -stimulates red bone marrow to produce more RBCs
 |  | 
        |  | 
        
        | Term 
 
        | Negative feedback of RBC production |  | Definition 
 
        | -cellular oxygen depletion stimulates RBC production -stimulates kidneys to lease erythropotietin
 -with rising levels of RBCs, less EPO is released
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | RBCs are drawn off and reinjected a few days before athletic event to increase RBC count - or artificial EPO is injected
 |  | 
        |  | 
        
        | Term 
 
        | What vitamins are necessary for DNA synthesis |  | Definition 
 
        | Vitamin B12 and folic acid |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | caused by low absorption of vitamin B12 |  | 
        |  | 
        
        | Term 
 
        | What percent of the body's iron supply is found in hemoglobin? |  | Definition 
 
        | 65% of body's iron supply |  | 
        |  | 
        
        | Term 
 
        | How is iron lost from the body? |  | Definition 
 
        | feces, urine, perspiration, menstruation |  | 
        |  | 
        
        | Term 
 
        | White blood cell characteristics |  | Definition 
 
        | -nucleated -no hemoglobin
 -larger than RBCs
 -less numerous than RBCs
 -granulocyte or agranulocyte
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -neutrophil -eosinophil
 -basophil
 |  | 
        |  | 
        
        | Term 
 
        | Characteristics of a neutrophil |  | Definition 
 
        | -polymorphonuclear leukocyte -pH neutral
 -nuclei 2-5 lobes
 -pink with Wright's stain
 -few granules
 -60-70% of all WBC
 |  | 
        |  | 
        
        | Term 
 
        | Characteristics of an eosinophil |  | Definition 
 
        | -bilobed nucleus -orange/red with Wright's stain
 -fights allergic reactions and parasitic worms
 -2-4%of all WBC
 -moderately granular
 |  | 
        |  | 
        
        | Term 
 
        | Characteristics of a basophil |  | Definition 
 
        | -irregular S-shaped nucleus -dark purple with Wright's stain
 -release histamine and heparin; local inflammatory response
 -.5% of all WBC
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Lymphocyte characteristics |  | Definition 
 
        | -dark, round nucleus -pale blue/gray with Wright's stain
 -2 types:
 - B-cells and T-cells
 -20-25% of all WBC
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -largest WBC in size* -kidney or horseshoe shaped nucleus
 -pale blue/gray with Wright's stain
 -macrophages
 -3-8% of all WBC
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -increase in number of WBC - protective response to stress
 - response to microbe invasion, strenuous exercise, anesthesia, and surgery
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -abnormal low WBC count -due to radiation, shock, chemotherapy agents
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -2% circulating in blood stream -most in lymph nodes, spleen, lungs, skin, connective tissues
 -active outside blood stream
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -WBCs leaving the bloodstream -move by ameboid movement
 |  | 
        |  | 
        
        | Term 
 
        | High count of neutrophils |  | Definition 
 
        | -due to bacterial infection, burns, stress, inflammation |  | 
        |  | 
        
        | Term 
 
        | High count of lymphocytes |  | Definition 
 
        | -viral infection, some leukemia |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -viral or fungal infection, TB, some leukemia |  | 
        |  | 
        
        | Term 
 
        | High count of eosinophils |  | Definition 
 
        | -allergic reactions, parasitic infections, autoimmune disease |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -allergic reactions, leukemia, cancers, hypothyroidism |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -intravenous transfer of red bone marrow -goal to establish normal hemopoiesis
 -replace diseased bone marrow
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -play a role in clotting -cell fragments, no nucleus
 -150,000-400,000/mm3 count
 -5-9 day lifespan
 -derive from Megakaryocytes
 - splinter into 2-3,000 fragments
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | -vascular spasm -platelet plug formation
 -blood clotting
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -pain receptor stimulation -reflex contraction of smooth muscle
 -reduces blood loss
 |  | 
        |  | 
        
        | Term 
 
        | Platelet plug formation chemicals |  | Definition 
 
        | -alpha granules -dense granules
 -enzymes (form thromboxane A2), fibrin stabilizing factor, lysosomes, and mitochondria
 -platelet derived growth factor
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | involved in platelet plug formation -contain clotting factors and (PDGF)
 -cause proliferation of vascular endothelial cells, smooth muscle fibers, and fibroblasts
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | involved in platelet plug formation -contain ADP, ATP, Ca2+, and serotonin
 |  | 
        |  | 
        
        | Term 
 
        | Platelet-derived growth factor (PDGF) |  | Definition 
 
        | hormone within platelet causing proliferation of endothelial cells and vascular smooth muscle |  | 
        |  | 
        
        | Term 
 
        | Steps of platelet plug formation |  | Definition 
 
        | -platelet adhesion -platelet release reaction
 -platelet aggregation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | platelets contact and stick to damage blood vessel with collagen fibers |  | 
        |  | 
        
        | Term 
 
        | Platelet release reaction |  | Definition 
 
        | platelets become activated -extend projections to allow contact with one another
 -release their chemicals
 -serotonin and thromboxane A2 function as vasoconstrictors
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -ADP causes other platelets to become sticky -they adhere to original activated platelets
 -accumulation and attachment of many platelets form a platelet plug
 -platelet plug reinforced with fibrin during coagulation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | clotting; series of chemical reactions involving clotting factors that ultimately forming fibrin threads |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | straw-colored liquid without clotting factors |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | consists of a network of insoluble protein fibers called fibrin that trap formed elements |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | clotting in an unbroken vessel |  | 
        |  | 
        
        | Term 
 
        | Clotting factor characteristics |  | Definition 
 
        | -they require Ca2+ *** -they inactivate enzymes formed in the liver so they don't clot unnecessarily
 -molecules associated with platelets
 -identified by Roman numerals
 |  | 
        |  | 
        
        | Term 
 
        | Clotting factor sequence of steps |  | Definition 
 
        | -formation of prothrombinase (by extrinsic or intrinsic pathways) -prothrombinase converts prothrombin into thrombin
 -thrombin converts fibrinogen into fibrin
 |  | 
        |  | 
        
        | Term 
 
        | Extrinsic pathway formation of prothrombinase |  | Definition 
 
        | -fewer steps and occurs more rapidly than intrinsic pathway -tissue factor (TF)(thromboplastin)leaks into blood vessel from outside cells
 -In the presence of Ca2+***, TF activates clotting factor X
 -Clotting factor X combines with factor V to form prothrombinase
 |  | 
        |  | 
        
        | Term 
 
        | Tissue factor (TF) thromboplastin |  | Definition 
 
        | a mixture of lipoprotein and phospholipids |  | 
        |  | 
        
        | Term 
 
        | Intrinsic pathway formation of prothrombinase |  | Definition 
 
        | -more complex, occurs over minutes -activators are within blood or through indirect contact
 -endothelial cells become rough and damaged exposing collagen fibers
 -platelets contact collagen fibers activating clotting factor XII; activates reactions to activate X
 -activated X combines with V to form prothrombinase; in presence of Ca2+
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -prothrombinase and Ca2+ catalyze the conversion of prothrombin to thrombin -thrombin in presence of Ca2+ converts fibrinogen to fibrin threads
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | 2 positive feedbacks of thrombin |  | Definition 
 
        | -acceleration of prothrombinase formation; in turn accelerates thrombin production -second thrombin activates platelets, reinforcing aggregation and release of platelet phospholipids
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | clot that is attached and not moving |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Steps of clot retraction and blood vessel repair |  | Definition 
 
        | -consolidation or tightening of fibrin clot -fibrin contracts and pulls damaged ends of vessel together
 -depends on adequate number of platelets
 -fibroblasts form connective tissue, new endothelial cells repair vessel lining
 |  | 
        |  | 
        
        | Term 
 
        | Role of vitamin K in clotting |  | Definition 
 
        | -required for synthesis of 4 clotting factors by hepatocytes (II, VII, IX, X) -present in colon bacteria
 -fat soluble and absorbed through intestinal lining
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | system of hemostatic control -dissolves small inappropriate clots
 -dissolves clots at site of damage once damage is repaired
 -fibrinolysis: dissolution of a clot
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | mechanism of hemostatic control -inactive plasma enzyme incorporated into a clot at the time of formation
 -activated to plasmin (fibrinolysin)by factor XII, tissue plasminogen activator (t-PA), and thrombin
 -plasmin dissolves the clot by digesting fibrin and inactivating fibrinogen, prothrombin, and factors V, VIII, and XII
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | stays localized in spite of positive feedback mechanism |  | 
        |  | 
        
        | Term 
 
        | Prostacyclin (prostaglandin) |  | Definition 
 
        | -produced by endothelial cells and WBC -opposes the actions of thromboxane A2
 -powerful inhibitor of platelet adhesion and release
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -anticoagulant produced by mast cells and basophils -combines with antithrombin III to increase effectiveness
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | lodging of embolus in the lungs |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | lodging of embolus in the brain |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | antagonist to vitamin K formation -comes from rat poison
 |  | 
        |  | 
        
        | Term 
 
        | Tissue plasminogen activator (tPA) |  | Definition 
 
        | genetically engineered product used to treat MI, and CVA caused by clots |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | antigen associated with blood |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Universal donor blood type |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | antigen originally identified in Rheus monkey |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | serum containing anti-Rh agglutinins -aggultinates the Rh factor and blocks the mother's immune response
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | destruction of baby's blood cells by antibodies from the mother as result of mother being Rh negative and baby being Rh positive |  | 
        |  | 
        
        | Term 
 
        | Universal recipient blood type |  | Definition 
 | 
        |  |